Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 1/20 | 0.44 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.43 |
| ▸ | KIF11 | P52732 | 3/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | CES2 | O00748 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | KCNJ11 | Q14654 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | METAP2 | P50579 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18241974 | 0.85 | PTPRC (0.42) | PTPRCTRPV1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL18243206 | 0.85 | KIF11 (0.41) | KIF11CYP1A1CYP1A2CYP1B1CES2 | |
| SCHEMBL18242057 | 0.82 | PTPRC (0.40) | PTPRCTRPV1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL18242345 | 0.81 | PTPRC (0.39) | PTPRCTRPV1CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL18243956 | 0.81 | TSHR (0.38) | PTPRCTRPV1CYP1A2CYP1B1TSHR | |
| SCHEMBL18241941 | 0.79 | PTPRC (0.40) | PTPRCTRPV1CYP1B1TSHR | |
| SCHEMBL10408737 | 0.78 | ALDH1A1 (0.56) | PTPRCKIF11CYP1A1CYP1A2CYP1B1 | |
| SCHEMBL23206122 | 0.77 | CYP1A2 (0.57) | PTPRCTRPV1KIF11CYP1A2TSHR | |
| SCHEMBL4078183 | 0.77 | F2 (0.49) | PTPRCTRPV1KIF11TSHRMAPK1 | |
| SCHEMBL4727635 | 0.77 | CTDSP1 (0.53) | PTPRCTRPV1KIF11CYP1A2CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | PTPRC 2973/4885TRPV1 1051/4885KIF11 3984/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | PTPRC 2973/4885TRPV1 1051/4885KIF11 3984/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.